Pretherapeutic Plasma Pro- and Anti- Inflammatory Mediators Are Related to High Risk of Oral Mucositis in Pediatric Patients with Acute Leukemia: A Prospective Cohort Study

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ye, Ying ^a,b   Carlsson, Göran ^c   Agholme, Monica Barr ^a   Karlsson Sjöberg, Jenny ^a   Yucel Lindberg, Tülay ^a   Pütsep, Katrin ^a   Modéer, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTACOID; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; POLYPEPTIDE ANTIBIOTIC AGENT; PRO CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; LYMPHOCYTOPENIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; ORAL MUCOSITIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SOLID TUMOR; THROMBOCYTOPENIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; LEUKEMIA; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; STOMATITIS;

EID: 84878531843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064918     Document Type: Article

References (30)

1. Sonis ST, (2004) Oral mucositis in cancer therapy. J Support Oncol 2: 3-8.
2. Scully C, Sonis S, Diz PD, (2006) Oral mucositis. Oral Dis 12: 229-241.
3. Sonis ST, (2009) Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45: 1015-1020.
4. Cheng KKF, Goggins WB, Lee VWS, Thompson DR, (2008) Risk factors for oral mucositis in children undergoing chemotherapy: A matched case-control study. Oral Oncol 44: 1019-1025.
5. Otmani N, Alami R, Soulaymani A, El Mokhtari A, Khattab M, (2008) Sex, age and ABO blood groups in chemotherapy-induced oropharyngeal mucositis. Minerva Stomatol 57: 505-509.
6. Otmani N, Alami R, Hessissen L, Mokhtari A, Soulaymani A, et al. (2011) Determinants of severe oral mucositis in paediatric cancer patients: a prospective study. Int J Paediatr Dent 21: 210-216.
7. Fadda G, (2006) Campus G, Luglie P (2006) Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy. BMC Oral Health 6: 13.
8. Figliolia SL, Oliveira DT, Pereira MC, Lauris JR, Mauricio AR, et al. (2008) Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis 14: 761-766.
9. Cheng KKF, (2008) Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer. Eur J Cancer Care (Engl) 17: 306-311.
10. Arya SBL, Anirudhan D, Bakhshi S, Xess I, (2008) Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia. Indian Pediatr 45: 47-51.
11. Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, et al. (2011) Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 47: 153-162.
12. Sonis ST, (2004) The pathobiology of mucositis. Nat Rev Cancer 4: 277-284.
13. Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, et al. (2008) Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 62: 33-41.
14. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, et al. (2008) Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7: 1139-1145.
15. Schauer MC, Holzmann B, Peiper M, Friess H, Knoefel WT, et al. (2010) Interleukin-10 and-12 Predict Chemotherapy-Associated Toxicity in Esophageal Adenocarcinoma. J Thorac Oncol 5: 1849-1854.
16. Keijser BJ, Zaura E, Huse SM, van der Vossen JM, Schuren FH, et al. (2008) Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res 87: 1016-1020.
17. Andersson M, Karlsson J, Carlsson G, Pütsep K, (2007) Expression of granule-associated proteins in neutrophils from patients with severe congenital neutropenia. Blood 110: 2772-2773.
18. Pütsep K, Carlsson G, Boman HG, Andersson M, (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360: 1144-1149.
19. Carlsson G, Wahlin YB, Johansson A, Olsson A, Eriksson T, et al. (2006) Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J Periodontol 77: 744-751.
20. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, et al. (1982) Adiposity indices in children. Am J Clin Nutr 36: 178-184.
21. WHO (1979) Handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization. 15-22 p.
22. Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, et al. (2010) Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer- a prospective pilot study. Radiat Oncol 5: 16.
23. Morales-Rojas T, Viera N, Moron-Medina A, Alvarez CJ, Alvarez A, (2011) Proinflammatory cytokines during the initial phase of oral mucositis in patients with acute lymphoblastic leukaemia. Int J Paediatr Dent 22: 191-196.
24. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, et al. (1995) FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A 92: 195-199.
25. Sørensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
26. Sørensen O, Cowland JB, Askaa J, Borregaard N, (1997) An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206: 53-59.
27. de Haar SF, Hiemstra PS, van Steenbergen MT, Everts V, Beertsen W, (2006) Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun 74: 5284-5291.
28. Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sora F, et al. (2003) Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 88: 192-200.
29. Gandemer V, Le Deley MC, Dollfus C, Auvrignon A, Bonnaure-Mallet M, et al. (2007) Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol 29: 86-94.
30. Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, et al. (1996) Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia. Bone Marrow Transplant 17: 31-37.